Brachytherapy for cervical cancer
This article has no abstract so we have provided the first paragraph of the full text.
Brachytherapy is widely used, in combination with external beam radiotherapy (EBRT), in the treatment of cervical cancer. It is unclear, however, whether high-dose-rate (HDR) brachytherapy is superior to the more traditional low-dose-rate (LDR) approach in terms of tumor control and complication rate. Lertsanguansinchai and colleagues have recently reported on a prospective, randomized trial comparing the two approaches.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.